NEW YORK (GenomeWeb News) – Prodesse has licensed two patents from Abbott that cover multiplexing and molecular detection technologies, the Wisconsin-based company said yesterday.
Under the agreement, Prodesse acquired non-exclusive sub-licenses for US Patent No. 5,582,989, and US Patent No. 5,851,767.
The '989 "Caskey" patent, assigned to Baylor College of Medicine, covers molecular multiplexing and the '767 "Stanbridge" patent, assigned to the University of California, covers molecular detection of prokaryotic organisms, mostly bacteria.
Baylor and UC exclusively licensed these patents to Abbott, with the right to grant sublicenses.
Financial terms of the agreement were not released.